Literature DB >> 30685356

Hepatic carboxylesterases are differentially regulated in PPARα-null mice treated with perfluorooctanoic acid.

Xia Wen1, Angela A Baker1, Curtis D Klaassen2, J Christopher Corton3, Jason R Richardson4, Lauren M Aleksunes5.   

Abstract

Hepatic carboxylesterases (Ces) catalyze the metabolism of drugs, environmental toxicants, and endogenous lipids and are known to be regulated by multiple nuclear receptors. Perfluorooctanoic acid (PFOA) is a synthetic fluorochemical that has been associated with dyslipidemia in exposed populations. In liver, PFOA can activate nuclear receptors such as PPARα, and alter the metabolism and excretion of chemicals. Here, we sought to test the ability of PFOA to modulate Ces expression and activity in the presence and absence of the PPARα receptor. For this purpose, male C57BL/6 NCrl mice were administered PFOA (1 or 3 mg/kg, po, 7 days) and livers collected for assessment of Ces expression and activity. PFOA increased Ces1 and 2 protein and activity. Notably, PFOA increased Ces1d, 1e, 1f, 1 g, 2c, and 2e mRNAs between 1.5- and 2.5-fold, while it decreased Ces1c and 2b. Activation of PPARα by PFOA was confirmed by up-regulation of Cyp4a14 mRNA. In a separate study of PFOA-treated wild-type (WT) and PPARα-null mice, induction of Ces 1e and 1f mRNA and in turn, Ces1 protein, was PPARα-dependent. Interestingly, in PPARα-null mice, Ces1c, 1d, 1 g, 2a, 2b, and 2e mRNAs and Ces2 protein were up-regulated by PFOA which contributed to sustained up-regulation of Ces activity, although to a lower extent than observed in WT mice. Activation of the CAR and PXR receptors likely accounted for up-regulation of select Ces1 and 2 subtypes in PPARα-null mice. In conclusion, the environmental contaminant PFOA modulates the expression and function of hepatic Ces enzymes, in part through PPARα.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Carboxylesterase; Ces; PFOA; PPARα

Mesh:

Substances:

Year:  2019        PMID: 30685356      PMCID: PMC6397673          DOI: 10.1016/j.tox.2019.01.014

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  50 in total

1.  Isoform-Specific Regulation of Mouse Carboxylesterase Expression and Activity by Prototypical Transcriptional Activators.

Authors:  Angela A Baker; Grace L Guo; Lauren M Aleksunes; Jason R Richardson
Journal:  J Biochem Mol Toxicol       Date:  2015-07-15       Impact factor: 3.642

2.  Liver specific inactivation of carboxylesterase 3/triacylglycerol hydrolase decreases blood lipids without causing severe steatosis in mice.

Authors:  Jihong Lian; Enhui Wei; Shu Pei Wang; Ariel D Quiroga; Lena Li; Alba Di Pardo; Jelske van der Veen; Simonetta Sipione; Grant A Mitchell; Richard Lehner
Journal:  Hepatology       Date:  2012-12       Impact factor: 17.425

3.  Characterization of the expression and activity of carboxylesterases 1 and 2 from the beagle dog, cynomolgus monkey, and human.

Authors:  Eric T Williams; James A Bacon; David M Bender; Jennifer J Lowinger; Wen-Kai Guo; Mariam E Ehsani; Xiliang Wang; He Wang; Yue-Wei Qian; Kenneth J Ruterbories; Steven A Wrighton; Everett J Perkins
Journal:  Drug Metab Dispos       Date:  2011-09-14       Impact factor: 3.922

4.  Altered expression of the carboxylesterases ES-4 and ES-10 by peroxisome proliferator chemicals.

Authors:  M Poole; K Bridgers; S E Alexson; J C Corton
Journal:  Toxicology       Date:  2001-08-28       Impact factor: 4.221

5.  Loss of TGH/Ces3 in mice decreases blood lipids, improves glucose tolerance, and increases energy expenditure.

Authors:  Enhui Wei; Yassine Ben Ali; James Lyon; Huajin Wang; Randy Nelson; Vernon W Dolinsky; Jason R B Dyck; Grant Mitchell; Gregory S Korbutt; Richard Lehner
Journal:  Cell Metab       Date:  2010-03-03       Impact factor: 27.287

Review 6.  PPARalpha: energy combustion, hypolipidemia, inflammation and cancer.

Authors:  Sean R Pyper; Navin Viswakarma; Songtao Yu; Janardan K Reddy
Journal:  Nucl Recept Signal       Date:  2010-04-16

7.  Differences in the induction of carboxylesterase isozymes in rat liver microsomes by perfluorinated fatty acids.

Authors:  M Hosokawa; T Satoh
Journal:  Xenobiotica       Date:  1993-10       Impact factor: 1.908

8.  Evaluation of perfluoroalkyl acid activity using primary mouse and human hepatocytes.

Authors:  Mitchell B Rosen; Kaberi P Das; Carmen R Wood; Cynthia J Wolf; Barbara D Abbott; Christopher Lau
Journal:  Toxicology       Date:  2013-04-06       Impact factor: 4.221

9.  Perfluorocarboxylic acids induce cytochrome P450 enzymes in mouse liver through activation of PPAR-alpha and CAR transcription factors.

Authors:  Xingguo Cheng; Curtis D Klaassen
Journal:  Toxicol Sci       Date:  2008-07-22       Impact factor: 4.849

10.  Serum perfluorooctanoic acid and hepatic enzymes, lipoproteins, and cholesterol: a study of occupationally exposed men.

Authors:  F D Gilliland; J S Mandel
Journal:  Am J Ind Med       Date:  1996-05       Impact factor: 2.214

View more
  2 in total

1.  Perfluorinated Carboxylic Acids with Increasing Carbon Chain Lengths Upregulate Amino Acid Transporters and Modulate Compensatory Response of Xenobiotic Transporters in HepaRG Cells.

Authors:  Joe Jongpyo Lim; Youjun Suh; Elaine M Faustman; Julia Yue Cui
Journal:  Drug Metab Dispos       Date:  2021-12-02       Impact factor: 3.579

2.  Combined Use of Bicyclol and Berberine Alleviates Mouse Nonalcoholic Fatty Liver Disease.

Authors:  Hu Li; Nan-Nan Liu; Jian-Rui Li; Biao Dong; Mei-Xi Wang; Jia-Li Tan; Xue-Kai Wang; Jing Jiang; Lei Lei; Hong-Ying Li; Han Sun; Jian-Dong Jiang; Zong-Gen Peng
Journal:  Front Pharmacol       Date:  2022-02-16       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.